Detail: Novel Inotropic Agent for Acute Heart Failure Looks Promising in Phase 2 Evaluation

Main Directory

Articles	2591
CME	2
eCommerce	0
Medical Web Sites Directory	93
Podcasts	94
Web Design and Hosting	2

Novel Inotropic Agent for Acute Heart Failure Looks Promising in Phase 2 Evaluation
Link ID	6320
Title	Novel Inotropic Agent for Acute Heart Failure Looks Promising in Phase 2 Evaluation
Url	http://www.medscape.com/viewarticle/575545?src=rss
Description	The inotropic and lusitropic istaroxime safely improved hemodynamics as well as systolic and, perhaps, diastolic function in the HORIZON-HF trial, now formally published. Heartwire
Category	Articles > Cardiology
Keywords
Date	Jun 6, 2008
Contact Name
Email
Write a Review Add to My Favorite Refer it to Friend Report Broken Link

Other links at Articles > Cardiology

Variations on the Theme of the Wenckebach Phenomenon (III)

Test your electrocardiographic skills. Does the tracing reveal VT with complete AV dissociation or...?
Medscape Cardiology

Category:

Articles > Cardiology

Managing Phosphorus in Chronic Kidney Disease (Slides With Audio)

Category:

Articles > Cardiology

Complete AV Block?

Or does the tracing show something else? You be the judge.
Medscape Cardiology

Category:

Articles > Cardiology

Plastic-Additive Bisphenol A Linked to Diabetes and Cardiovascular Events in NHANES Analysis

The current study is among the largest of its kind and may be the first to associate bisphenol A with chronic disease in humans. Medscape Medical News

Category:

Articles > Cardiology

Once-a-Day Carvedilol "Noninferior" to Twice-Daily Version in Heart Failure; Need for it Questioned

Some believe once-daily carvedilol for heart failure will improve compliance and therefore outcomes, compared with the twice-daily version; others wonder whether noninferiority is worth the extra cost. Heartwire

Category:

Articles > Cardiology